Medicines & drugs recalls
909 recalls since January 2025 from Health Canada, FDA, newest first. Last notice 19 Nov 2026.
909recalls on record
Page 14 of 19
- Health CanadaMylan-Cinacalcet: Affected lots exceed the established acceptable intake limit for N-nitroso-cinacalcet.Health CanadaProduct quality
- FDAKABANA SKIN CARE recalls GreenScreen and 3 moreFDACGMP deviations
- FDAMacleods Pharmaceuticals Ltd recalls Famciclovir TabletsFDAPresence of Foreign Substance- Black hair strand found attached to a tablet in a sealed bottle.
- FDABreckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release CapsulesFDACGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
- Health CanadaTaro-Doxorubicin Liposomal: may contain particulate matterHealth CanadaProduct quality
- Health CanadaTwin Rivers Farm Ltd. recalls one lot of Surf Banana Split dried cannabis pre-rolls, one lot of Surf Layer Cake dried cannabis pre-rolls, and one lot of Surf Mac dried cannabis pre-rollsHealth CanadaLabelling and packaging
- Health CanadaApo-Dutasteride 0.5 mg: Affected lot may contain undersized capsulesHealth CanadaProduct quality
- FDATailstorm Health INC recalls KETAmine Hydrochloride Injection and 3 moreFDALack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
- FDAChurch & Dwight Inc recalls Orajel Baby and 2 moreFDAMicrobial Contamination of Non-Sterile Products: Fungal contamination of infant oral swabs.
- FDAOrient Pharma Co., Ltd. Yunlin Plant recalls Pitavastatin TabletsFDAFailed Impurities/Degradation Specifications.
- FDAThe Harvard Drug Group LLC recalls Gabapentin CapsulesFDADefective container; blister packaging inadequately sealed.
- FDAGranules Pharmaceuticals Inc. recalls Metoprolol Succinate Extended-Release TabletsFDAFailed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH)…
- FDASandoz Inc recalls Cefazolin for Injection and 1 moreFDALabeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were found to contain vials labeled as penicillin G potassium for Injection,…
- FDAAvKARE recalls Pitavastatin TabletsFDAFailed Impurity/Degradation Specifications
- Health CanadaNRA-AMLODIPINE 5MG: Affected lot may contain tablet(s) of Metoprolol Succinate prolonged–release 12.5 mg tabletsHealth CanadaProduct safety
- Health CanadaAnesketin : Presence of particulate matter in the affected lotsHealth CanadaProduct quality
- Health CanadaPMS-Methylphenidate CR 10 mg capsule; exceed the acceptable intake limit for N-nitroso-methylphenidateHealth CanadaProduct quality
- Health CanadaRIVA-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit for N-nitroso-fluoxetineHealth CanadaProduct quality
- FDAThrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) recalls Semaglutide and 8 moreFDALack of Assurance of Sterility
- FDAFresenius Medical Care Holdings, Inc. recalls .9% Sodium Chloride InjectionFDALack of Assurance of Sterility
- FDATeva Pharmaceuticals USA, Inc recalls Metoclopramide TabletsFDAPresence of foreign tablets/capsules.
- FDAPfizer Inc. recalls DOBUTamine InjectionFDADiscoloration; discolored solution from cracked vials
- FDAApotex Corp. recalls Ketorolac Tromethamine Ophthalmic Solution and 2 moreFDALack of Assurance of Sterility
- FDAAdvanced Pharmaceutical Technology, Inc. recalls TESTO-200FDAMarketed Without an Approved NDA/ANDA
- FDAB BRAUN MEDICAL INC recalls .9% Sodium Chloride Injection USPFDALack of assurance of sterility: pinholes, within the finger boxes used during Form Fill Seal process resulting in leaks.
- Health CanadaPMS-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit for N-nitroso-fluoxetineHealth CanadaProduct quality
- Health CanadaDr. Nutrition 360 Magnesium 200 mg capsule; Incorrect non-medicinal ingredient (Gelatin)Health CanadaProduct quality
- Health CanadaPRO-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit for N-nitroso-fluoxetineHealth CanadaProduct quality
- Health CanadaYi Li Xiao Capsule; Undeclared prescription drug (Tadalafil)Health CanadaProduct quality
- FDAAurobindo Pharma USA Inc recalls Acetaminophen TabletsFDACGMP deviations: Due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets).
- FDAUmary-USA.com recalls UNAVY ACIDO HIALURONICO and 1 moreFDAMarketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and…
- FDAEugia US LLC recalls Gentamicin InjectionFDAFailed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.
- Health CanadaGamunex solution; may cause allergic / hypersensitivity type reactionHealth CanadaAdverse reaction
- Health CanadaAccel-Ondansetron ODT 4 & 8 mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.Health CanadaProduct quality
- Health CanadaTeva-Piroxicam 10 mg capsule; Out of specification (Dissolution)Health CanadaProduct quality
- FDASAINI TRADE INC recalls ELECTRO BUZZ and 4 moreFDAMarketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared chloropretadalafil,…
- FDAAlembic Pharmaceuticals Limited recalls Celecoxib CapsulesFDAPresence of Foreign Tablets/Capsules; customer complaint found one Tadalafil 5mg tablet inside a sealed 500-count bottle of Celecoxib 200mg capsule
- FDAAvKARE recalls Chlorthalidone TabletsFDAFailed Dissolution Specifications
- FDAGlenmark Pharmaceuticals Inc., USA recalls Ezetimibe and Simvastatin TabletsFDAFailed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time…
- FDAAvKARE recalls Celecoxib CapsulesFDAPresence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg…
- FDAAscend Laboratories, LLC recalls Cephalexin for Oral SuspensionFDAFailed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of…
- FDAZydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl Capsules 1 gramFDAFailed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation…
- FDAMacleods Pharmaceuticals Ltd recalls Levothyroxine Sodium TabletsFDAPresence of a foreign substance: black hair found embedded in tablet.
- FDAAmneal Pharmaceuticals, LLC recalls Sulfamethoxazole and Trimethoprim TabletsFDAMicrobial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.
- Health CanadaWeiteling tablet; Missing medical ingredient Bletilla striata & incorrect expiry dateHealth CanadaProduct quality
- Health CanadaJuHong TanKe JianGao liquid; missing medicinal ingredient "Glycyrrhiza uralensis" on labelHealth CanadaProduct quality
- Health CanadaKimmtrak Solution; Out of specification (in-vitro potency assay)Health CanadaProduct quality
- FDAAmerisource Health Services LLC recalls Indomethacin Extended-Release CapsulesFDACGMP deviations
- FDAApotex Corp. recalls Lacosamide Oral SolutionFDADefective Container: This recall is being initiated due to a leaking unit stored horizontally.
- FDAConsumer Product Partners, LLC recalls Spectrum Advanced Gel Hand SanitizerFDASubpotent product: Product has cloudy appearance and tested below assay label claim for 70% Ethyl Alcohol